The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ikuo Saito

Health Center

School of Medicine

Keio University

Kanagawa

Japan

[email]@hc.cc.keio.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Health Center, School of Medicine, Keio University, Kanagawa, Japan. 2002 - 2011
  • Keio University Health Center, Yokohama, Japan. 2008 - 2010

References

  1. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE). Saito, I., Suzuki, H., Kageyama, S., Saruta, T. Clin. Exp. Hypertens. (2011) [Pubmed]
  2. Use of home blood pressure monitoring and exercise, diet and medication compliance in Japan. Saito, I., Nomura, M., Hirose, H., Kawabe, H. Clin. Exp. Hypertens. (2010) [Pubmed]
  3. The use of olmesartan medoxomil as monotherapy or in combination with other antihypertensive agents in elderly hypertensive patients in Japan. Saito, I., Kushiro, T., Hirata, K., Sato, Y., Kobayashi, F., Sagawa, K., Hiramatsu, K., Komiya, M. J. Clin. Hypertens. (Greenwich) (2008) [Pubmed]
  4. Early antihypertensive efficacy of olmesartan medoxomil. Saito, I., Kushiro, T., Ishikawa, M., Matsushita, Y., Sagawa, K., Hiramatsu, K., Komiya, M. J. Clin. Hypertens. (Greenwich) (2008) [Pubmed]
  5. Cost-effectiveness analysis: controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study. Saito, I., Fujikawa, K., Saruta, T. Hypertens. Res. (2008) [Pubmed]
  6. Cost-utility analysis of antihypertensive combination therapy in Japan by a Monte Carlo simulation model. Saito, I., Kobayashi, M., Matsushita, Y., Mori, A., Kawasugi, K., Saruta, T. Hypertens. Res. (2008) [Pubmed]
  7. Prevalence of metabolic syndrome in young men in Japan. Saito, I., Mori, M., Shibata, H., Hirose, H., Tsujioka, M., Kawabe, H. J. Atheroscler. Thromb. (2007) [Pubmed]
  8. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study. Saito, I., Saruta, T. Hypertens. Res. (2006) [Pubmed]
  9. Effect of education through a periodic newsletter on persistence with antihypertensive therapy. Saito, I., Saruta, T. Hypertens. Res. (2003) [Pubmed]
  10. Relation between blood pressure control, body mass index, and intensity of medical treatment. Saito, I., Murata, K., Hirose, H., Tsujioka, M., Kawabe, H. Hypertens. Res. (2003) [Pubmed]
  11. Relation between blood pressure and rhinitis in a Japanese adolescent population. Saito, I., Mori, M., Shibata, H., Hirose, H., Tsujioka, M., Kawabe, H. Hypertens. Res. (2003) [Pubmed]
  12. Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. First Japanese Society of Hypertension. Saito, I., Kawabe, H., Tsujioka, M., Hirose, H., Shibata, H. Hypertens. Res. (2002) [Pubmed]
 
WikiGenes - Universities